Published in Clin Exp Allergy on December 01, 2002
Key issues for the assessment of the allergenic potential of genetically modified foods: breakout group reports. Environ Health Perspect (2003) 1.53
Oil body-associated hazelnut allergens including oleosins are underrepresented in diagnostic extracts but associated with severe symptoms. Clin Transl Allergy (2014) 0.80
Effects of autoclaving and high pressure on allergenicity of hazelnut proteins. J Clin Bioinforma (2012) 0.76
Development of a monoclonal antibody-based sandwich ELISA for peanut allergen Ara h 1 in food. Int J Environ Res Public Health (2013) 0.75
Spiking with recombinant allergens to improve allergen extracts: benefits and limitations for the use in routine diagnostics: Part 19 of the Series Molecular Allergology. Allergo J Int (2015) 0.75
Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10. Lancet (2000) 4.32
Will genetically modified foods be allergenic? J Allergy Clin Immunol (2001) 2.36
The diagnosis of food allergy: a systematic review and meta-analysis. Allergy (2013) 2.23
Treatment of infantile haemangiomas with atenolol: comparison with a historical propranolol group. J Plast Reconstr Aesthet Surg (2013) 2.11
[Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis]. Ned Tijdschr Geneeskd (2005) 2.03
The CREATE project: development of certified reference materials for allergenic products and validation of methods for their quantification. Allergy (2008) 1.96
Standardization of food challenges in patients with immediate reactions to foods--position paper from the European Academy of Allergology and Clinical Immunology. Allergy (2004) 1.81
Poor biologic activity of cross-reactive IgE directed to carbohydrate determinants of glycoproteins. J Allergy Clin Immunol (1997) 1.76
T cell responses to major peanut allergens in children with and without peanut allergy. Clin Exp Allergy (2010) 1.67
[Body dysmorphic disorder in 3-8% of patients in outpatient dermatology and plastic surgery clinics]. Ned Tijdschr Geneeskd (2006) 1.54
Immunological cross-reactivity between lipid transfer proteins from botanically unrelated plant-derived foods: a clinical study. Allergy (2002) 1.54
Differential expression of IgE and IgG4 specific antibody responses in asymptomatic and chronic human filariasis. J Immunol (1993) 1.51
The prevalence of parasite infestation and house dust mite sensitization in Gabonese schoolchildren. Int Arch Allergy Immunol (2001) 1.47
Relevance of Ara h1, Ara h2 and Ara h3 in peanut-allergic patients, as determined by immunoglobulin E Western blotting, basophil-histamine release and intracutaneous testing: Ara h2 is the most important peanut allergen. Clin Exp Allergy (2004) 1.47
Early-life rotavirus and norovirus infections in relation to development of atopic manifestation in infants. Clin Exp Allergy (2008) 1.44
Cross-reactivity of IgE antibodies to allergens. Allergy (2001) 1.42
Hazelnut allergy differs between children and adults in frequency of severity, aetiology and relevance of diagnostic parameters. Clin Exp Allergy (2014) 1.41
[Two patients with hypereosinophilic syndrome]. Ned Tijdschr Geneeskd (2006) 1.39
Sandwich enzyme-linked immunosorbent assay (ELISA) for detection of mustard in foods. J Food Sci (2008) 1.39
[Mucocutaneous manifestations of amyloidosis]. Ned Tijdschr Geneeskd (2007) 1.35
Molecular fingerprinting of the intestinal microbiota of infants in whom atopic eczema was or was not developing. Clin Exp Allergy (2006) 1.28
The prevalence, cost and basis of food allergy across Europe. Allergy (2007) 1.26
Children with peanut allergy recognize predominantly Ara h2 and Ara h6, which remains stable over time. Clin Exp Allergy (2007) 1.25
Acute allergic reactions in children with AEDS after prolonged cow's milk elimination diets. Allergy (2006) 1.23
Does skin prick test reactivity to purified allergens correlate with clinical severity of peanut allergy? Clin Exp Allergy (2007) 1.16
The affinity and stoichiometry of binding of human factor VIII to von Willebrand factor. Blood (1995) 1.16
Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis. Allergy (2005) 1.14
The multinational birth cohort of EuroPrevall: background, aims and methods. Allergy (2009) 1.14
Toxicity of triorganotin compounds: comparative in vivo studies with a series of trialkyltin compounds and triphenyltin chloride in male rats. Toxicol Appl Pharmacol (1985) 1.13
Purification and immunoglobulin E-binding properties of peanut allergen Ara h 6: evidence for cross-reactivity with Ara h 2. Clin Exp Allergy (2005) 1.13
Assessment of the safety of foods derived from genetically modified (GM) crops. Food Chem Toxicol (2004) 1.11
Birch pollen sensitization with cross-reactivity to food allergens predominates in adults with eosinophilic esophagitis. Allergy (2013) 1.09
A multi-laboratory evaluation of a common in vitro pepsin digestion assay protocol used in assessing the safety of novel proteins. Regul Toxicol Pharmacol (2004) 1.08
Phototherapy of acne vulgaris with visible light. Dermatology (1997) 1.08
Possible induction of food allergy during mite immunotherapy. Allergy (1996) 1.07
cDNA cloning of a major allergen from timothy grass (Phleum pratense) pollen; characterization of the recombinant Phl pV allergen. J Immunol (1993) 1.07
[Double-blind placebo-controlled cow's milk challenge for children in general hospitals]. Ned Tijdschr Geneeskd (2006) 1.05
Biological activity of organotin compounds--an overview. Environ Res (1987) 1.03
SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis. Br J Dermatol (2001) 1.03
Peanut allergen Ara h 3: isolation from peanuts and biochemical characterization. Allergy (2003) 1.01
Efficacy of birch-pollen immunotherapy on cross-reactive food allergy confirmed by skin tests and double-blind food challenges. Clin Exp Allergy (2004) 1.01
Geographic and temporal variations in pollen exposure across Europe. Allergy (2014) 1.01
Evaluation by double-blind placebo-controlled oral challenge of the clinical relevance of IgE antibodies against plant glycans. Allergy (2008) 1.00
Crossreactive carbohydrate determinants. Clin Rev Allergy Immunol (1997) 1.00
Standardization of allergen products: 1. Detailed characterization of GMP-produced recombinant Bet v 1.0101 as biological reference preparation. Allergy (2009) 1.00
Oral sensitization to food proteins: a Brown Norway rat model. Clin Exp Allergy (1998) 0.99
The prevalence and distribution of food sensitization in European adults. Allergy (2013) 0.98
Diesel exhaust, carbon black, and silica particles display distinct Th1/Th2 modulating activity. Toxicol Appl Pharmacol (2000) 0.98
The effect of the food matrix on in vivo immune responses to purified peanut allergens. Toxicol Sci (2005) 0.98
Identification and partial characterization of multiple major allergens in peanut proteins. Clin Exp Allergy (1998) 0.98
Geographical variation in the prevalence of sensitization to common aeroallergens in adults: the GA(2) LEN survey. Allergy (2014) 0.97
Fatty acids in breast milk and development of atopic eczema and allergic sensitisation in infancy. Allergy (2011) 0.97
Photosensitivity in patients with lupus erythematosus: a clinical and photobiological study of 100 patients using a prolonged phototest protocol. Br J Dermatol (2003) 0.96
A consensus protocol for the determination of the threshold doses for allergenic foods: how much is too much? Clin Exp Allergy (2004) 0.96
Prevalence and distribution of sensitization to foods in the European Community Respiratory Health Survey: a EuroPrevall analysis. Allergy (2010) 0.95
Is Candida albicans a trigger in the onset of coeliac disease? Lancet (2003) 0.95
Factor VIII and von Willebrand factor. Thromb Haemost (1998) 0.95
Lipid transfer protein: a pan-allergen in plant-derived foods that is highly resistant to pepsin digestion. Int Arch Allergy Immunol (2000) 0.94
E-health in caring for patients with atopic dermatitis: a randomized controlled cost-effectiveness study of internet-guided monitoring and online self-management training. Br J Dermatol (2012) 0.94
An evaluation of the sensitivity of subjects with peanut allergy to very low doses of peanut protein: a randomized, double-blind, placebo-controlled food challenge study. J Allergy Clin Immunol (1997) 0.93
Diagnostic accuracy of specific IgE to components in diagnosing peanut allergy: a systematic review. Clin Exp Allergy (2015) 0.93
Properties of tree and grass pollen allergens: reinvestigation of the linkage between solubility and allergenicity. Int Arch Allergy Immunol (1993) 0.92
Maintenance of tolerance to cow's milk in atopic individuals is characterized by high levels of specific immunoglobulin G4. Clin Exp Allergy (2007) 0.92
Thresholds for food allergens and their value to different stakeholders. Allergy (2008) 0.92
Glucose transport in Salmonella typhimurium and Escherichia coli. Eur J Biochem (1982) 0.92
Mixed antibody and T cell responses to peanut and the peanut allergens Ara h 1, Ara h 2, Ara h 3 and Ara h 6 in an oral sensitization model. Clin Exp Allergy (2004) 0.91
Immune-mediated effects upon oral challenge of ovalbumin-sensitized Brown Norway rats: further characterization of a rat food allergy model. Toxicol Appl Pharmacol (1999) 0.91
Kinetics of factor VIII-von Willebrand factor association. Blood (1996) 0.91
Structural aspects of cross-reactivity and its relation to antibody affinity. Allergy (2001) 0.91
Prevalence and severity of allergic rhinitis in house dust mite-allergic patients with bronchial asthma or atopic dermatitis. Clin Exp Allergy (2002) 0.90
Components in soy allergy diagnostics: Gly m 2S albumin has the best diagnostic value in adults. Allergy (2013) 0.90
Food allergen (peanut)-specific TH2 clones generated from the peripheral blood of a patient with peanut allergy. J Allergy Clin Immunol (1996) 0.90
Efficacy and safety of long-term treatment with cyclosporin A for atopic dermatitis. J Eur Acad Dermatol Venereol (2007) 0.89
A mutant of the major apple allergen, Mal d 1, demonstrating hypo-allergenicity in the target organ by double-blind placebo-controlled food challenge. Clin Exp Allergy (2005) 0.89
Specific IgE without clinical allergy. J Allergy Clin Immunol (1999) 0.89
Dibutyltin and tributyltin compounds induce thymus atrophy in rats due to a selective action on thymic lymphoblasts. Int J Immunopharmacol (1988) 0.89
Comparison of antibody responses to hen's egg and cow's milk proteins in orally sensitized rats and food-allergic patients. Allergy (2000) 0.89
The diagnostic accuracy of specific IgE to Ara h 6 in adults is as good as Ara h 2. Allergy (2014) 0.88
Diagnostic value of outcome measures following allergen exposure in an environmental challenge chamber compared with natural conditions. Clin Exp Allergy (2010) 0.88